维普期刊资源整合服务平台（V6.5）

222篇 您的检索式：作者名="Donehower"

选中清除导出查看参考文献查看引证文献引用追踪共12页首页上一页第1页下一页末页 /12 跳转

	题名	作者	年代	出处	被引量
1	Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study显示文摘	Timothy Iveson Ross C Donehower Irina Davidenko Sergey Tjulandin Andrzej Deptala Mark Harrison Somanath Nirni Kuntegowdanahalli Lakshmaiah Anne Thomas Yizhou Jiang Min Zhu Rui Tang Abraham Anderson Sarita Dubey Kelly S Oliner Elwyn Loh	2014	Lancet Oncology2014，，9：	3
2	Integrated preclinical and clinical development of S- trans, trans -farnesylthiosalicylic acid (FTS, Salirasib) in pancreatic cancer显示文摘	Daniel Laheru Preeti Shah N. V. Rajeshkumar Florencia McAllister Gretchen Taylor Howard Goldsweig Dung T. Le Ross Donehower Antonio Jimeno Sheila Linden Ming Zhao Dongweon Song Michelle A. Rudek Manuel Hidalgo	2012	Investigational New Drugs2012，，6：	2
3	Incidence and prognostic impact of KRAS and BRAF mutation in patients undergoing liver surgery for colorectal metastases显示文摘	Georgios Karagkounis Michael S. Torbenson Hubert D. Daniel Nilofer S. Azad Luis A. Diaz Ross C. Donehower Kenzo Hirose Nita Ahuja Timothy M. Pawlik Michael A. Choti	2013	Cancer2013，，23：	2
4	Paclitaxel (Taxol) 显示文摘	Row insky EK Donehower RC	1995	N Engl J Med1995，332，15：	1
5	Phase Ⅱ study of flavopiridol in patients with advanced colorectal cancer 显示文摘	Aklilu M Kindler HL Donehower RC	2003	Annals of Oncology2003，14，8：	1
6	Hypersensi- tivity reactions from taxol 显示文摘	Weiss RB Donehower RC Wiernik PH	1990	J Clin Oncol1990，8，7：	1
7	Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors显示文摘	Donehower L A Harvey M Slagle B M	1992	Nature1992，356，：	1
8	The tumor suppressor p53显示文摘	Bradlley A	1993	Biochen Biophysica Acta1993，1155，：	1
9	Hypersensitivity reactions from taxol显示文摘	Weiss RB Donehower RC Wiernik PH	1990	J Clin Oncol1990，8，7：	1
10	Hypersensitivity reactions from taxol显示文摘	WEISS R B DONEHOWER R C WIERNIK P H	1990	J Clin Oncol1990，8，7：	1
11	Hyper-sensitivity reactions from taxol显示文摘	Weiss RB Donehower RC Wiernik PH		0，，07：	1
12	Hypersensitivety reactions from taxol显示文摘	Donehower RC Wierrik PH etal	1990	J Clin Oncol1990，8，7：	1
13	Phase Ⅰ and pharmacodynamic study of the topoisomerase I-inhibitor topotecan in patients with refractory aucte leukemia显示文摘	Rowinsky EK Adjiei R Donehower RC	1994	J Clin Oncol1994，12，：	1
14	20 years studying p53 functions in genetically engineered mice显示文摘	Donehower LA Lozano G	2009	Nat Rev Cancer2009，9，11：	1
15	Hypscrcnsitivity reactions from taxol显示文摘	Weiss RB Donehower RC Wierrik PH	1990	J Chin Oncol1990，8，7：	1
16	Hypersensitivity reaction from taxol显示文摘	Weiss RB Donehower RC Wiernik PH	1990	J Clin Oncol1990，8，7：	1
17	A phase Ⅰ pharmacokinetic and pharmacodynamic study of the DNA methyltransferase 1 inhibitor MG98 administered twice weekly显示文摘	STEWART DJ DONEHOWER RC EISENHAUER EA	2003	Ann Oncol2003，14，5：	1
18	Paclitaxel (Taxol) 显示文摘	ROWINSKY R K DONEHOWER R C	1995	N Engl J Med1995，332，：	1
19	Using mice to examine p53 functions in cancer,aging,and longevity显示文摘	Lawrence A Donehower A	2009	Cold Spring Harb Perspect Biol2009，1，00：	1
20	Mice deficient for p53 are developmentally normabut susceptible to spontaneous显示文摘	Donehower LA Harveg M Slagle BL	1992	Nature1992，356，：	1

返回顶部每页显示：

共12页首页上一页第1页下一页末页 /12 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示